BioAtla Stock (NASDAQ: BCAB) stock price, news, charts, stock research, profile.
You can purchase shares of BioAtla (NASDAQ:BCAB) through any online brokerage.
Other companies in BioAtla’s space includes: NKGen Biotech (NASDAQ:NKGN), Outlook Therapeutics (NASDAQ:OTLK), HOOKIPA Pharma (NASDAQ:HOOK), OncoCyte (NASDAQ:OCX) and Intensity Therapeutics (NASDAQ:INTS).
BioAtla has a consensus price target of $14.17.
The stock price for BioAtla (NASDAQ: BCAB) is $0.63 last updated December 24, 2024 at 4:43 PM EST.
There are no upcoming dividends for BioAtla.
BioAtla’s Q4 earnings are confirmed for Tuesday, March 25, 2025.
There is no upcoming split for BioAtla.
BioAtla is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.